Markets Mixed: Poor Economic Data Weighs Against Biotech Mega-Deal

Now watching

Next video starts in : 7 Play

Markets Mixed: Poor Economic Data Weighs Against Biotech Mega-Deal

Markets Mixed: Poor Economic Data Weighs Against Biotech Mega-Deal
Replay video
Up next

American don't feel appreciated at work: Monster poll

Unlock your personal NFL Now stream by signing in to NFL.com

Markets Mixed: Poor Economic Data Weighs Against Biotech Mega-Deal

by TheStreet.com Videos 2:23 mins

Markets closed mixed Tuesday as poor manufacturing data and housing sentiment was weighed against a $25 billion deal in the biotech sector. Treasury yield moves suggest poor weather is not entirely to blame for lackluster economic data. Forest Laboratories jumped 29% after Actavis agreed to buy the maker of the Alzheimer's drug Namenda. Coca-Cola Co. shed nearly 4% as fourth-quarter profit fell. Homebuilders also dropped as a gauge of homebuilder confidence dived by the most on record in February amid bad weather. TheStreet's Jane Searle speaks with GreyWolf Execution's Mark Newton as the New York Stock Exchange.

View Comments (0)